Tenderwize
Back to tender search

Rituximab medicines – Open House Biologika 2026

Techniker Krankenkasse·Hamburg, Germany·Deadline Nov 29, 2028 · 758 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 29 Rituximab (nur Fertigarzneimittel)

0/100

Opportunity Score

High riskLow complexity
SuppliesOpen
Why this score?

Opportunity

0 / 100

Complexity

0 / 100

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
Techniker Krankenkasse
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Nov 29, 2028

AI tender analysis

Tenderwize prepares an AI analysis of this tender based on the TED notice and procurement documents: scope of work, key requirements, eligibility criteria, risks and questions for the buyer. The analysis is generated when the tender is opened.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Biologika Rabattverträge 2026 - 29 Rituximab (nur Fertigarzneimittel)

Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zu dem Wirkstoff Rituximab (nur Fertigarzneimittel exklusive Darreichungsform zur subkutanen Injektion) zu schließen.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Nov 2026 - Nov 2028

Category

Pharmaceutical products

Procurement Details

Publication date
01 Nov 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
759317-2026

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy